[ad_1]
In the Netherlands, a clinical trial of Viagra as a growth factor was discontinued after the deaths of the babies of 11 mothers treated with Viagra. The British "Guardian" reports, citing Dutch sources. The series of tests was conducted in ten Dutch hospitals and included a total of 93 women receiving Viagra and a comparison group of another 90 pregnant women taking a placebo. In the Viagra group, 17 babies developed lung problems after birth, eleven of whom died later, according to an independent committee. In the control group, only three babies suffered from these symptoms and all survived.
The women involved had a poorly formed placenta and their fetuses became less developed. Based on experiments with rats, some of them should take the drug Sildenafil Viagra, so that their uterus better blood circulation and therefore growing children are better taken care of. Viagra is known to dilate blood vessels and is therefore taken by people with erectile dysfunction – erectile dysfunction – and also prescribed for people with hypertension as an antidote. According to the Guardian, sildenafil is now believed to have caused high blood pressure in the lung tissue still tender from the unborn child, which is why babies may have been underfed with oxygen. There is no evidence that the series of experiments was wrongly addressed.
Gynecologist Wessel Ganzevoort of University Hospital Amsterdam, who participated in the study, told the Dutch media that the doctors were shocked. They also informed a Canadian research group that also conducted such a test – it was also stopped. The series of tests in the Netherlands started in 2015 and is expected to continue until 2020. A study conducted in the UK with Viagra as a growth promoting drug in the unborn child has been published in 2017: it did not provide convincing evidence of efficacy or risk for patients. In the Netherlands, there are currently between 10 and 15 women waiting to see if their children have been injured by the test.
Source link
